Hester Biosciences Limited (HESTERBIO.NS)
INR 2459.15
(1.23%)
INR 2459.15
(1.23%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 755.81 Million INR | -4.59% |
| 2022 | 792.16 Million INR | 5.09% |
| 2021 | 753.82 Million INR | 21.15% |
| 2020 | 622.22 Million INR | -2.73% |
| 2019 | 639.67 Million INR | 25.96% |
| 2018 | 507.85 Million INR | 27.74% |
| 2017 | 397.57 Million INR | 18.99% |
| 2016 | 334.11 Million INR | -0.62% |
| 2015 | 336.2 Million INR | 15.5% |
| 2014 | 291.08 Million INR | -18.21% |
| 2013 | 355.89 Million INR | 14.43% |
| 2012 | 311.02 Million INR | 12.84% |
| 2011 | 275.62 Million INR | 0.0% |
| 2010 | - INR | 0.0% |
| 2009 | - INR | 0.0% |
| 2008 | - INR | 0.0% |
| 2007 | - INR | 0.0% |
| 2006 | - INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 672 Million INR | 0.0% |
| 2023 FY | 755.81 Million INR | -4.59% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 803.83 Million INR | 0.0% |
| 2023 Q4 | 755.81 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 792.16 Million INR | 0.0% |
| 2022 Q2 | 767.35 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 792.16 Million INR | 5.09% |
| 2021 Q2 | 622.82 Million INR | 0.0% |
| 2021 Q4 | 753.82 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 753.82 Million INR | 21.15% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 622.22 Million INR | -2.73% |
| 2020 Q4 | 622.22 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 616.52 Million INR | 0.0% |
| 2019 Q2 | 579.32 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 639.67 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 639.67 Million INR | 25.96% |
| 2018 FY | 507.85 Million INR | 27.74% |
| 2018 Q4 | 507.85 Million INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 397.57 Million INR | 18.99% |
| 2016 FY | 334.11 Million INR | -0.62% |
| 2015 FY | 336.2 Million INR | 15.5% |
| 2014 FY | 291.08 Million INR | -18.21% |
| 2013 FY | 355.89 Million INR | 14.43% |
| 2012 Q2 | 592.04 Million INR | 0.0% |
| 2012 FY | 311.02 Million INR | 12.84% |
| 2012 Q4 | 311.02 Million INR | 0.0% |
| 2011 FY | 275.62 Million INR | 0.0% |
| 2010 FY | - INR | 0.0% |
| 2009 FY | - INR | 0.0% |
| 2008 FY | - INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2006 FY | - INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | -6.873% |
| Ind-Swift Limited | 640.91 Million INR | -17.927% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 47.527% |
| Sakar Healthcare Limited | 277.32 Million INR | -172.538% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.229% |
| Innova Captab Limited | 1.44 Billion INR | 47.519% |
| Divi's Laboratories Limited | 31.84 Billion INR | 97.626% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 66.833% |
| Morepen Laboratories Limited | 2.48 Billion INR | 69.597% |
| Mankind Pharma Limited | 15.53 Billion INR | 95.135% |
| Sequent Scientific Limited | 3.46 Billion INR | 78.17% |
| Wanbury Limited | 360.23 Million INR | -109.812% |
| Laurus Labs Limited | 18.45 Billion INR | 95.904% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 89.342% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 88.662% |
| Alembic Limited | 113.4 Million INR | -566.499% |
| Hikal Limited | 3.03 Billion INR | 75.115% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.401% |
| Neuland Laboratories Limited | 3.5 Billion INR | 78.431% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 84.959% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 96.992% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 82.21% |
| Themis Medicare Limited | 705.74 Million INR | -7.094% |
| RPG Life Sciences Limited | 1.01 Billion INR | 25.167% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 97.804% |
| Lupin Limited | 49.53 Billion INR | 98.474% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -161.483% |
| Wockhardt Limited | 6.4 Billion INR | 88.19% |
| Vaishali Pharma Limited | 3.79 Million INR | -19805.452% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 88.243% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -403.974% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 94.139% |
| FDC Limited | 3.88 Billion INR | 80.565% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.811% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -1795.211% |
| Eris Lifesciences Limited | 1.89 Billion INR | 60.017% |
| Venus Remedies Limited | 1.21 Billion INR | 37.891% |
| ZIM Laboratories Limited | 812.62 Million INR | 6.992% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 36.19% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -1709.457% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 79.181% |
| Shilpa Medicare Limited | 3.44 Billion INR | 78.088% |
| Albert David Limited | 436.12 Million INR | -73.303% |
| Ajanta Pharma Limited | 8.28 Billion INR | 90.876% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 67.309% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 78.988% |
| Gufic Biosciences Limited | 2 Billion INR | 62.3% |
| Windlas Biotech Limited | 621.89 Million INR | -21.534% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 30.73% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -117.965% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 38.87% |
| Granules India Limited | 13 Billion INR | 94.189% |
| Aarti Drugs Limited | 4.85 Billion INR | 84.445% |
| Bal Pharma Limited | 878.11 Million INR | 13.928% |
| Alkem Laboratories Limited | 26.61 Billion INR | 97.16% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.234% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 2.057% |
| Medicamen Biotech Limited | 593.75 Million INR | -27.294% |
| Unichem Laboratories Limited | 7.04 Billion INR | 89.274% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -154.981% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2864.31% |
| Valiant Laboratories Limited | 100.15 Million INR | -654.648% |
| Orchid Pharma Limited | 2.64 Billion INR | 71.395% |
| Medico Remedies Limited | 163.37 Million INR | -362.631% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -622.731% |
| Ipca Laboratories Limited | 24.71 Billion INR | 96.942% |
| Brooks Laboratories Limited | 96.1 Million INR | -686.417% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -258.518% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.684% |
| NATCO Pharma Limited | 7 Billion INR | 89.21% |
| Suven Life Sciences Limited | 7.08 Million INR | -10567.749% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -671.518% |
| Strides Pharma Science Limited | 11.26 Billion INR | 93.289% |
| Indoco Remedies Limited | 3.53 Billion INR | 78.593% |
| Alpa Laboratories Limited | 136.65 Million INR | -453.087% |
| Lasa Supergenerics Limited | 190.43 Million INR | -296.888% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -5009.586% |